Product Name: ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methyl thiazole-5-carboxylate CAS 161798-01-2
5-Thiazolecarboxylic acid, 2-(3-formyl-4-hydroxyphenyl)-4-methyl-, ethyl ester;
Chemical & Physical Properties:
Appearance : white powder
Boiling Point:446.7℃ at 760 mmHg
Febuxostat can reduce the level of uric acid in patients with hyperuricemia gout. Gout is a group of heterogeneous diseases, which is caused by hereditary or acquired uric acid excretion reduction and purine metabolism disorder. Due to the excessive production of uric acid in the body and the decline of renal clearance capacity, uric acid accumulates in the body, resulting in the deposition of urate crystals in joints and organs. Therefore, the treatment of gout usually takes the following measures: promoting uric acid excretion and inhibiting uric acid production, and taking appropriate measures to improve the related symptoms.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.